This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
A U.S. judge ordered federal agencies to restore access to health-related webpag...
Having kicked off the year with a T-cell engager deal, AbbVie has returned to th...
The company's HIV sales surged 16% during the quarter, setting the scene for its...
Get your daily dose of health and medicine every weekday with STAT’s free newsle...
Apple is launching a new study to investigate the relationships between differen...
Sanofi-backed Abcuro has secured $200 million in series C funds to power its ant...
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Dat...
Opinion/decision on a Paediatric investigation plan (PIP): Vaxzevria (previously...
Biogen has bagged $250 million to advance a key pipeline prospect. Royalty Pharm...
Terrain Biosciences, backed by high-profile players in biotech, will design and ...
After Merck KGaA's recent confirmation that it's in discussions to acquire Sprin...
Antimicrobial Sales and Use (ASU) Platform: Release notes
After calling Rockville, Maryland, home for more than eight years, pharma giant ...
EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9...
HMPC meeting report on European Union herbal monographs, guidelines and other ac...
After calling Rockville, Maryland home for more than eight years, pharma giant G...
Human medicines European public assessment report (EPAR): Duloxetine Viatris (pr...
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir...
“Building a much better scientific enterprise means embracing the idea of collab...
Fears about corn, canola, and similar oils have taken root amid rising concerns ...
The settlement in U.S. v. Gilead could disturb the model of public-private partn...